Skip to content
10-Q

Quarterly Report

ALZAMEND NEURO, INC. ALZN

0001214659-26-003166

← back to feed
Filed
Mar 11, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Mar 11, 2026 3.8M sh
Shares Diluted Q3 2026 · Jan 31, 2026 3.8M sh
Shares Diluted Q3 2026 · Jan 31, 2026 3.12M sh
Shares Diluted restated Q3 2026 · Jan 31, 2025 611.98K sh
Shares Diluted restated Q3 2026 · Jan 31, 2025 362.86K sh
Operating Cash Flow Q3 2026 · Jan 31, 2026 −$5.27M
Operating Cash Flow Q3 2026 · Jan 31, 2025 −$5.88M
Cash And Equivalents Q3 2026 · Jan 31, 2026 $2.71M
Cash And Equivalents Q3 2026 · Apr 30, 2025 $3.95M
Stockholders Equity Q3 2026 · Jan 31, 2026 $2.18M
Stockholders Equity Q3 2026 · Oct 31, 2025 $4.37M
Stockholders Equity Q3 2026 · Apr 30, 2025 $3.97M
Stockholders Equity Q3 2026 · Jan 31, 2025 $3.45M
Stockholders Equity Q3 2026 · Oct 31, 2024 $3.75M
Stockholders Equity Q3 2026 · Apr 30, 2024 −$2.59M
Total Liabilities Q3 2026 · Jan 31, 2026 $1.86M
Total Liabilities Q3 2026 · Apr 30, 2025 $634.76K
Current Assets Q3 2026 · Jan 31, 2026 $3.7M
Current Assets Q3 2026 · Apr 30, 2025 $4.18M
Total Assets Q3 2026 · Jan 31, 2026 $4.04M
Total Assets Q3 2026 · Apr 30, 2025 $4.6M
Eps Diluted Q3 2026 · Jan 31, 2026 −$0.58
Eps Diluted Q3 2026 · Jan 31, 2026 −$1.89
Eps Diluted restated Q3 2026 · Jan 31, 2025 −$1.75
Eps Diluted restated Q3 2026 · Jan 31, 2025 −$9.54
Eps Basic Q3 2026 · Jan 31, 2026 −$0.58
Eps Basic Q3 2026 · Jan 31, 2026 −$1.89
Eps Basic restated Q3 2026 · Jan 31, 2025 −$1.75
Eps Basic restated Q3 2026 · Jan 31, 2025 −$9.54
Sga Expense Q3 2026 · Jan 31, 2026 $919.03K
Sga Expense Q3 2026 · Jan 31, 2026 $2.7M
Sga Expense Q3 2026 · Jan 31, 2025 $590.3K
Sga Expense Q3 2026 · Jan 31, 2025 $2.39M
Rd Expense Q3 2026 · Jan 31, 2026 $1.28M
Rd Expense Q3 2026 · Jan 31, 2026 $3.2M
Rd Expense Q3 2026 · Jan 31, 2025 $447.11K
Rd Expense Q3 2026 · Jan 31, 2025 $964.77K
Net Income Q3 2026 · Jan 31, 2026 −$2.2M
Net Income Q3 2026 · Jan 31, 2026 −$5.9M
Net Income Q3 2026 · Jan 31, 2025 −$1.04M
Net Income Q3 2026 · Jan 31, 2025 −$3.38M
Operating Income Q3 2026 · Jan 31, 2026 −$2.2M
Operating Income Q3 2026 · Jan 31, 2026 −$5.9M
Operating Income Q3 2026 · Jan 31, 2025 −$1.04M
Operating Income Q3 2026 · Jan 31, 2025 −$3.36M